Zhejiang will be 17 kinds of anti-cancer drugs into health insurance and the first time to carry out special centralized procurement of anti-cancer drugs

, zhejiang daily January 17 news, reduce the burden of patient medication, Zhejiang first step! On January 16, the reporter learned from the Zhejiang Medical Security Bureau that 17 anti-cancer drugs will be included in the scope of reimbursement of health insurance Class B drugs in Zhejiang Province, and for the first time carried out a special centralized procurement of anti-cancer drugs, which is expected to save nearly 900 million yuan per year.
recent years, molecular targeting and other effectiveness of anti-cancer drugs have been listed, causing social concern and patient expectations, but enjoy patents, exclusive anti-cancer drugs at a higher price, patient cost burden. Last October, the National Health Insurance Administration issued a notice to include 17 negotiated cancer drugs in Medicare Category B, and simultaneously set the standard of payment for these drugs. Zhejiang Province became the first province in the country to land the results of negotiations, as of December 14 last year, 17 anti-cancer drugs in the province accumulated drug costs of 52.66 million yuan, a total of 3,422 patients enjoy policy benefits, estimated to save 560 million yuan per year.
, Zhejiang Cancer Hospital has been prepared for this time into the health insurance of a total of 13 anti-cancer drugs. "Take the targeted drug 'Teresa' for the treatment of lung cancer as an example, in the past a box of prices of 51,000 yuan and self-funded, the current price of 153,000 yuan and included in the list of medical insurance reimbursement of Class B, patients only need to bear about 3000 yuan per box." Cheng Bin, deputy director of the medical insurance office of Zhejiang Cancer Hospital, told reporters.
reporter learned that in 17 anti-cancer drugs, 9 from the major disease insurance negotiated drugs to medical insurance reimbursement drugs, 8 from self-funded drugs directly into medical insurance reimbursement drugs, the vast majority of drugs paid for by medical insurance.
, Zhejiang Province also carried out the first time a special centralized procurement of anti-cancer drugs, the average price of the winning product fell by 11.56%.